Product image of Lappoxo (Omeprazole) supplied by GNH India

Lappoxo

Active Ingredient:
Omeprazole
Origin:
EU

Lappoxo (Omeprazole)

Omeprazole, the active ingredient in Lappoxo, is a proton pump inhibitor presented as an oral dosage form for systemic use. It reduces gastric acid production and is prescribed for acid‑related disorders such as gastro‑oesophageal reflux disease, peptic ulcer disease, and for ulcer prevention in patients taking non‑steroidal anti‑inflammatory drugs.

GNH India supplies Lappoxo as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides reliable sourcing for regulated markets.

Manufacturer / TM Owner

Alkaloid-Int D.O.O.

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

  • Omeprazole is used to treat conditions caused by excess gastric acid secretion.
  • Gastro‑oesophageal reflux disease (GERD): alleviates heartburn and esophageal irritation by maintaining a higher gastric pH.
  • Peptic ulcer disease: promotes healing of gastric and duodenal ulcers by reducing acid exposure.
  • Helicobacter pylori eradication regimens: used as part of combination therapy to increase antibiotic effectiveness.
  • Prevention of NSAID‑induced gastric ulcers: lowers ulcer risk in patients requiring long‑term non‑steroidal anti‑inflammatory drug therapy.

How It Works

  • Omeprazole irreversibly binds to the H+/K+ ATPase enzyme (the proton pump) located on the secretory surface of gastric parietal cells. By inhibiting this final step of acid secretion, it markedly reduces the volume and acidity of gastric juice, leading to an elevated intragastric pH. The effect persists until new proton pumps are synthesized, typically 24–48 hours after a dose and provides symptomatic relief.

Side Effects

Omeprazole may be associated with a range of adverse reactions, varying from mild to severe.

Common Side Effects

  • Headache: mild, transient headache reported in some patients.
  • Diarrhea: loose stools or increased bowel movements.
  • Abdominal pain: discomfort or cramping in the stomach area.
  • Nausea: feeling of sickness or urge to vomit.

Serious or Rare Side Effects

  • Clostridioides difficile infection: severe colitis due to overgrowth of C. difficile.
  • Acute interstitial nephritis: sudden kidney inflammation presenting with rash and renal dysfunction.
  • Fracture risk: increased incidence of hip, wrist or spine fractures with long‑term use.

Precautions & Warnings

When prescribing omeprazole, clinicians should consider several safety and handling measures.

  • Assess renal function: dose adjustment may be required in severe renal impairment.
  • Monitor for infection: prolonged acid suppression can predispose to gastrointestinal infections.
  • Evaluate bone health: long‑term therapy may affect calcium absorption and bone density.
  • Review concomitant medications: potential interactions may necessitate timing adjustments.
  • Store at ambient temperature: keep below 25 °C, protect from moisture and light in the original packaging.

Avoid Interactions

Omeprazole can alter the pharmacokinetics of several drugs, requiring careful management.

Major Interactions (Avoid)

  • Clopidogrel: reduced antiplatelet effect, may increase cardiovascular risk.
  • Atazanavir: markedly decreased absorption, leading to therapeutic failure.

Moderate Interactions (Monitor Closely)

  • Warfarin: enhanced anticoagulant effect, monitor INR closely.
  • Diazepam: increased plasma levels, observe for sedation.
  • Methotrexate (high dose): decreased renal clearance, monitor toxicity.

Frequently Asked Questions

Lappoxo, containing omeprazole, is indicated for the management of gastro‑oesophageal reflux disease, healing of gastric and duodenal ulcers, inclusion in Helicobacter pylori eradication regimens, and prevention of gastric ulcers associated with long‑term non‑steroidal anti‑inflammatory drug use.

Omeprazole irreversibly blocks the H+/K+ ATPase enzyme, also known as the proton pump, on gastric parietal cells. This inhibition stops the final step of acid secretion, leading to a sustained increase in gastric pH and reduced acidity, which helps heal acid‑related lesions.

The appropriate dose of Lappoxo is determined by the prescribing clinician based on the specific indication, severity of disease, patient age, renal function, and any concomitant therapies. Patients should follow the exact regimen provided by their healthcare professional.

Safety data for omeprazole in pregnancy and lactation are limited. It should only be used if the potential benefit justifies any possible risk to the fetus or infant. Women who are pregnant, planning pregnancy, or breastfeeding should discuss treatment options with their physician.

To request Lappoxo, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Lappoxo (omeprazole) belongs to the same class as esomeprazole, lansoprazole and pantoprazole. All PPIs share a similar mechanism of action, but individual agents differ slightly in pharmacokinetic profiles, drug‑interaction potential and cost. Clinical choice often depends on physician preference, patient response and formulary considerations.

Lappoxo should be stored at ambient temperature, below 25 °C, in its original packaging. Protect the product from moisture, excessive heat and direct sunlight to maintain its stability and potency throughout its shelf life.

Lappoxo is taken orally, usually as a whole tablet swallowed with a glass of water. It is generally recommended to take the dose before a meal, but patients should follow the specific instructions given by their prescriber.

Serious adverse events associated with omeprazole include Clostridioides difficile‑associated colitis, acute interstitial nephritis, and an increased risk of bone fractures with long‑term use. Patients should report persistent diarrhea, unexplained rash, kidney‑related symptoms, or signs of fracture to their healthcare provider promptly.

Lappoxo is contraindicated in individuals with known hypersensitivity to omeprazole or any component of the formulation. Caution is advised for patients with severe liver disease, those taking certain medications such as clopidogrel or atazanavir, and patients who have experienced previous adverse reactions to proton pump inhibitors.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Omeprazole

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT